Skip to main content
. Author manuscript; available in PMC: 2011 Sep 1.
Published in final edited form as: Bioorg Med Chem Lett. 2010 Jul 8;20(17):5191–5194. doi: 10.1016/j.bmcl.2010.07.005

Scheme 2.

Scheme 2

Synthesis of PAMAM G5-RFn-MTXm nanoconjugate 7. Reagents and conditions: i) EDC, 4-dimethylaminopyridine (DMAP), riboflavin, DMF, rt, 24 h; ii) 1, EDC, DMAP, DMF, rt, 24 h.

HHS Vulnerability Disclosure